Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.

In 1907 the late Dr. Harvey Cushing, the foremost brain surgeon of his era, declined an invitation to join the faculty of the Yale Medical School on the grounds that its hospital was "no damn good." ...